Showing results (91-100 of 119) with videos related to
Sort By:
Pageof 12
DNA and Cell Biology|July 1, 1990
The uses of computer-aided signal peptide selection and polymerase chain reaction in gene construction and expression of secreted proteinsB L Daugherty, S M Zavodny, A B Lenny, et al.AIDS (London, England)|February 10, 1998
Filgrastim prevents severe neutropenia and reduces infective morbidity in patients with advanced HIV infection: results of a randomized, multicenter, controlled trial. G-CSF 930101 Study GroupD R Kuritzkes, D Parenti, D J Ward, et al.The Journal of Infectious Diseases|June 1, 1989
Serum beta 2-microglobulin decreases in patients with AIDS or ARC treated with azidothymidineM A Jacobson, D I Abrams, P A Volberding, et al.The Journal of Infectious Diseases|April 11, 2001
Cytomegalovirus (CMV)-specific CD4+ T lymphocyte immune function in long-term survivors of AIDS-related CMV end-organ disease who are receiving potent antiretroviral therapyM A Jacobson, R Schrier, J M McCune, et al.BMJ (Clinical Research Ed.)|January 12, 1991
Surrogate markers for survival in patients with AIDS and AIDS related complex treated with zidovudineM A Jacobson, P Bacchetti, A Kolokathis, et al.Biochemistry|July 18, 1995
Stimulation by alkylxanthines of chloride efflux in CFPAC-1 cells does not involve A1 adenosine receptorsK A Jacobson, C Guay-Broder, P J van Galen, et al.Molecular Immunology|September 1, 1990
Heavy and light chain contributions to antigen binding in an anti-digoxin chain recombinant antibody produced by transfection of cloned anti-digoxin antibody genesR I Near, S C Ng, M Mudgett-Hunter, et al.Journal of Molecular and Cellular Cardiology|March 29, 2001
Targeted deletion of the A3 adenosine receptor confers resistance to myocardial ischemic injury and does not prevent early preconditioningY Guo, R Bolli, W Bao, et al.Protein Expression and Purification|June 1, 1993
Expression, purification and characterization of multigram amounts of a recombinant hybrid HV1-HV2 hirudin variant expressed in Saccharomyces cerevisiaeE D Lehman, J G Joyce, F J Bailey, et al.Antimicrobial Agents and Chemotherapy|May 1, 1994
Pharmacodynamic relationship of pharmacokinetic parameters of maintenance doses of foscarnet and clinical outcome of cytomegalovirus retinitisM A Jacobson, B Polsky, D Causey, et al.Pageof 12